| Literature DB >> 24052461 |
Hassane Izzedine1, Jean Charles Soria, Bernard Escudier.
Abstract
Oncologists and nephrologists usually manage proteinuria related to anti-vascular endothelial growth factor (anti-VEGF) treatment only when it is in the nephrotic range or associated with renal insufficiency. This report is based on our personal experience with 78 patients developing renal problems with anti-VEGF therapy. We found that proteinuria induced by anti-VEGF therapy, even if weak and without associated renal insufficiency, may reflect a serious histological renal disease.Entities:
Mesh：
Substances：
Year: 2013 PMID： 24052461 DOI： 10.5301/jn.5000307
Source DB: PubMed Journal: J Nephrol ISSN： 1121-8428 Impact factor: 3.902